PUBLIC CONTRACT · 2023
231000165 - Aquisição de sofosbuvir 400 mg + velpatasvir 100 mg + voxilaprevir 100 mg comp
- Contract value
- €46,183.83
- Signed on
- 23 February 2023
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9833506PUBLISHED DESCRIPTION
231000165 - 38739
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GILEAD SCIENCES, LDA · Tax ID 503604704
Values and timeline
- Contract price
- €46,183.83
- Procedure base price
- €46,184.04
- Total effective price
- Not reported on Portal BASE
- Publication date
- 2 March 2023
- Award date
- 20 February 2023
- Signing date
- 23 February 2023
- Performance period
- 318 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2021/67 - Medicamentos para a Hepatite C crónica
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6344533
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.